{"schema":"hottub-news/prospects/v1","item":{"id":"n_duzme2yo2yz54wzuhn2a","title":"FDA adds rare blindness warning to popular GLP-1 drugs","title_en":null,"url":"https://www.independent.co.uk/bulletin/news/glp-blindness-ozempic-zepbound-mounjaro-b3082540.html","outlet":"The Independent","published":"2026-11-10T15:22:53Z","sponsored":false,"page":"https://hottub.news/articles/n_duzme2yo2yz54wzuhn2a"},"prospects":[{"name":"Julia Musto","kind":"person","role":"reporter","company":"The Independent","website":"https://independent.co.uk/","source":"https://www.independent.co.uk/bulletin/news/glp-blindness-ozempic-zepbound-mounjaro-b3082540.html","note":"Wrote: FDA adds rare blindness warning to popular GLP-1 drugs","reason":"Reporter at The Independent; wrote “FDA adds rare blindness warning to popular GLP-1 drugs” on 2026-11-10","group":"Reporters","add_url":"https://crm.joinhottub.com/relationships/add#name=Julia%20Musto&company=The%20Independent&website=https%3A%2F%2Findependent.co.uk%2F&source=https%3A%2F%2Fwww.independent.co.uk%2Fbulletin%2Fnews%2Fglp-blindness-ozempic-zepbound-mounjaro-b3082540.html&note=Wrote%3A%20FDA%20adds%20rare%20blindness%20warning%20to%20popular%20GLP-1%20drugs","propose":{"name":"Julia Musto","kind":"person","reason":"Reporter at The Independent; wrote “FDA adds rare blindness warning to popular GLP-1 drugs” on 2026-11-10","requestId":"news:n_duzme2yo2yz54wzuhn2a:Reporter:a2622c64:3d6de30e","company":"The Independent","website":"https://independent.co.uk/","sourceUrl":"https://www.independent.co.uk/bulletin/news/glp-blindness-ozempic-zepbound-mounjaro-b3082540.html"}},{"name":"The Independent","kind":"organization","role":"outlet","website":"https://independent.co.uk/","entity":"wikidata:Q11149","source":"https://www.independent.co.uk/bulletin/news/glp-blindness-ozempic-zepbound-mounjaro-b3082540.html","note":"Published: FDA adds rare blindness warning to popular GLP-1 drugs (2026-11-10)","reason":"Published “FDA adds rare blindness warning to popular GLP-1 drugs” on 2026-11-10","group":"Outlet","add_url":"https://crm.joinhottub.com/relationships/add#name=The%20Independent&kind=organization&website=https%3A%2F%2Findependent.co.uk%2F&source=https%3A%2F%2Fwww.independent.co.uk%2Fbulletin%2Fnews%2Fglp-blindness-ozempic-zepbound-mounjaro-b3082540.html&entity=wikidata%3AQ11149&note=Published%3A%20FDA%20adds%20rare%20blindness%20warning%20to%20popular%20GLP-1%20drugs%20%282026-11-10%29","propose":{"name":"The Independent","kind":"organization","reason":"Published “FDA adds rare blindness warning to popular GLP-1 drugs” on 2026-11-10","requestId":"news:n_duzme2yo2yz54wzuhn2a:wikidata:Q11149:3cb3381d","website":"https://independent.co.uk/","sourceUrl":"https://www.independent.co.uk/bulletin/news/glp-blindness-ozempic-zepbound-mounjaro-b3082540.html","entity":"wikidata:Q11149"}}],"someone_else":{"source":"https://www.independent.co.uk/bulletin/news/glp-blindness-ozempic-zepbound-mounjaro-b3082540.html","note":"In the news: FDA adds rare blindness warning to popular GLP-1 drugs (The Independent, 2026-11-10)"},"crm":{"name":"CRM by Hottub","add":"Open add_url in a browser: CRM by Hottub's add form, filled in. Nothing is saved until the person presses Add.","mcp":"https://crm.joinhottub.com/api/crm/mcp","tool":"propose_relationship","propose":"If you're connected to CRM by Hottub's MCP server with proposal access, call propose_relationship with `propose` as its arguments. An owner approves it before anything is added. Keep the arguments as given: retries reuse requestId."}}